Non-secretory plasma cell myeloma of the true non-producer type
Primary intracerebral Hodgkin lymphoma
Immunodeficiency and immunotherapy in multiple myeloma
The risk associated with indwelling catheters in children with haemophilia
Myocardial iron loading by magnetic resonance imaging T2* in good prognostic myelodysplastic syndrome patients on long-term blood transfusions
Multiple myeloma plasma cells show different chemokine receptor profiles at sites of disease activity
Constitutive Fms-like tyrosine kinase 3 activation results in specific changes in gene expression in myeloid leukaemic cells
Hydroxycarbamide in combination with azacitidine or decitabine is antagonistic on DNA methylation inhibition
Preferential hypermethylation of the Dickkopf-1 promoter in core-binding factor leukaemia
Activation of sphingosine kinase mediates suppressive effect of interleukin-6 on human multiple myeloma cell apoptosis
Lenalidomide-induced myelosuppression is associated with renal dysfunction
AKAP12, a gene with tumour suppressor properties, is a target of promoter DNA methylation in childhood myeloid malignancies
Podocytes express ADAMTS13 in normal renal cortex and in patients with thrombotic thrombocytopenic purpura
An Sp1 binding site mutation of the PROS1 promoter in a patient with protein S deficiency
Distinguishing between non-identical twins
Killer cell immunoglobulin-like receptor/3DL2 expression in adult T-cell leukaemia
The leukaemia-associated antigen, SSX2IP, is expressed during mitosis on the surface of myeloid leukaemia cells